Details of Drug

Details of Drug

 Drug General Information (ID: D1184)
  Drug Name
Oprelvekin
  Drug Type Interferons
  Drug Synonymous
Neumega; Neumega (TN); Oprelvekin (genetical recombination); Oprelvekin (USAN/INN); Oprelvekin (genetical recombination) (JAN)
    Click to Show/Hide
  Disease Class 3B64: Thrombocytopenia
  Therapeutic Class Platelet-Stimulating Agents
  External Link
TTD ID D0T1IJ

Drug-Drug Interaction Network
  Sunburst Graph
AM006  Pharmacodynamic additive effects
BM047  Additive thrombogenic effects
BM065  Increased risk of hypokalemia
  Relation Graph
 Full list of drugs interacting with Oprelvekin
      Pharmacodynamic additive effects
   Additive thrombogenic effects Drug Num:  1
Drug ID
 
Drug Name
 Formula Pubchem ID Severity Level Interaction Detail REF
D0261
 
Carfilzomib
 
C40H57N5O7
 
11556711 
Major    Inter Info   
[1], [2], [3]
   Increased risk of hypokalemia Drug Num:  1
Drug ID
 
Drug Name
 Formula Pubchem ID Severity Level Interaction Detail REF
D0790
 
Ifosfamide
 
C7H15Cl2N2O2P
 
3690 
Major    Inter Info   
[4]
References
1 Cerner Multum, Inc. "Australian Product Information.".
2 Product Information. Kyprolis (carfilzomib). Onyx Pharmaceuticals Inc, South San Francisco, CA.
3 Cerner Multum, Inc. "UK Summary of Product Characteristics.".
4 Product Information. Neumega (oprelvekin). Genetics Institute, Cambridge, MA.